Abstract
Space-time analysis of mortality risk is useful to evaluate the epidemiologic transitions at the subnational level. In this study, we analysed the death certificate records for lung cancer in Italy in 1995-2016, obtained from the Italian National Statistics Institute. Our objective was to investigate the spatio-temporal evolution of lung cancer mortality by sex and province of residence (n = 107) using the birth cohort as relevant time axis. We built space-time Bayesian models with space-time interactions. Among men (n = 554,829), mortality peaked in the 1920-1929 cohort, followed by a generalised decline. Among women (n = 158,619), we found novel original evidence for a peak in the 1955-1964 cohort, equivalent to a 35-year delay, with a downward trend being observed thereafter. Over time, the documented north-south decreasing mortality gradient has been replaced by a west-east decreasing gradient. Naples has become the province at highest risk in Italy, both among men and women. This pattern is consistent with an epidemiologic transition of risk factors for lung cancer to the south-west of the country and raises concerns, because 5-year age-standardised net survival from the disease in this geographic area is lower than in northern and central Italy. The variability of mortality rates among provinces has changed over time, with an increasing homogeneity for men and an opposite trend for women in the more recent birth cohorts. These unprecedented observations update substantially previous knowledge on lung cancer mortality in Italy.
What’s new?The epidemiologic transition of lung cancer mortality in Italy (1995-2016) was studied using space-time Bayesian models with space-time interactions. Among men, mortality peaked in the 1920-1929 cohort, followed by a decline. Among women, novel evidence was found for a peak in the 1955-1964 cohort, equivalent to a 35-year delay, with a downward trend thereafter. The north-south decreasing gradient has been replaced by a west-east decreasing gradient, with Naples currently being the province at highest risk.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any external funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Ethics Committee at the Romagna Cancer Institute (ID: IRST100.37).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding information This study did not receive any external funding.
Dolores Catelan: Dolores.Catelan{at}ubep.unipd.it
Annibale Biggeri: annibale.biggeri{at}ubep.unipd.it
Lauro Bucchi: lauro.bucchi{at}irst.emr.it
Valerio Manno: velerio.manno{at}iss.it
Marilena Pappagallo: marilena.pappagallo{at}istat.it
Francesco Grippo: frgrippo{at}istat.it
Luisa Frova: frova{at}istat.it
Federica Zamagni: federica.zamagni{at}irst.emr.it
Roberta Crialesi: crialesi{at}istat.it
Giada Minelli: giada.minelli{at}iss.it
Giorgia Stoppa: Giorgia.Stoppa{at}ubep.unipd.it
Data Availability
Research data are available from Giada Minelli upon reasonable request.
ABBREVIATIONS
- CI
- confidence interval
- ICD
- International Classification of Diseases
- ISTAT
- Istituto Nazionale di Statistica
- RR
- relative risk
- SMR
- standardised mortality ratio
- U.K.
- United Kingdom